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Adding Specificity to
Artificial Transcription Activators
In this issue, Mapp and colleagues describe a signifi- [
cant advance in the design of artificial transcription t
activators that function in a cell-type-specific manner. t[1] The authors show that peptides selected for bind- s
ing a component of the yeast transcription complex A
require its presence for effective transcriptional acti- [
vation. f
r
An overriding goal for chemical biologists is to develop t
tools for decoding the complicated networks of pro- s
tein-protein interactions that execute the genetic pro- t
gram of an organism. One intricate and incompletely f
understood cellular process involves the initiation of s
transcription that ultimately leads to the transfer of in- f
formation from DNA into RNA. Transcriptional activa- f
tors that govern the expression of a specified gene are d
minimally composed of two modules: a sequence-spe- t
cific DNA binding domain (DBD) that finds the promoter t
region of interest, and an activation domain (AD) that
recruits the appropriate cellular machinery to the pro- t
moter via protein-protein interactions (Figure 1) [2]. t
Chemists are aiming to develop synthetic transcrip- p
tion activators (and repressors) that can selectively c
modulate the expression of any gene of interest [3]. Re- r
cent research efforts have afforded several ligands for c
sequence-specific binding of target DNA. These de- A
signed DBDs include pyrrole-imidazole polyamides [4], o
peptide nucleic acids [5], triplex-forming oligonucleo- n
tides [6], and zinc finger proteins [7]. While the DNA p
binding properties of these molecules have been char- a
acterized in detail, the precise role of the ADs in tran- i
scription has not been as clearly defined. The ADs are w
involved in the recruitment of coactivators, chromatin- t
modifying enzymes, and other components of the tran- f
scriptional machinery. Although several ADs may bind
to a common target in transcriptional machinery, unlike w
DBDs they do not always share defined structural mo- A
tifs [2]. a
Activation domains comprised of multiple acidic and e
hydrophobic residues (“acidic activators”) function ef-
fectively in eukaryotes. An important feature of these
strong ADs may be their ability to interact with multiple
targets in the transcription complex [2]. But if this
promiscuity is a necessary qualification for a strong AD,
it may be difficult to build ADs that are cell-type- and
species-specific. Thus, a key question for the develop-
ment of next generation of transcription activators is
whether potent activation can be achieved by specifi-
cally targeting individual components of the transcrip-
tional machinery. Several research groups have now
begun addressing this fundamental issue by creating
ligands for distinct proteins found in the transcription
complex. Montminy and Kodadek utilized phage dis-
play to isolate peptide ligands for p300/CREB binding
Fprotein (a histone acetyltransferase) and yeast repres-xperiments raise a number of intriguing questions re-
igure 1. Activation of Gene Transcriptiond. DOI 10.1016/j.chembiol.2005.03.002
or (Gal80), respectively, and have shown that these
eptides are strong activators of transcription [8, 9].
chepartz and coworkers have explored miniature pro-
ein scaffolds that display α-helical motifs to isolate
igh-affinity ligands for the CREB binding protein (CBP)
10]. The isolated miniprotein afforded a potent activa-
or of p300/CBP-dependent transcription when fused
o a Gal4 DBD [11]. Uesugi and coworkers used a
mall-molecule library to isolate ligands that mimic the
D of ESX (an epithelial-specific transcription factor)
12, 13]. Subsequently, these small-molecule ADs were
used to a sequence-specific DNA binding domain de-
ived from pyrrole-imidazole polyamides to create syn-
hetic transcription factors [14]. The Uesugi approach
hows that it is possible to generate small-molecule ac-
ivators by identifying inhibitors of the transcription
actor-target protein interactions. Mapp and coworkers
uccessfully showed that small-molecule transcription
actors may also be constructed by incorporating key
unctional groups from acidic activators into isoxazoli-
ine-based scaffolds [15]. This strategy elegantly
ranslates the amphipathic nature of the acidic activa-
ors into the small-molecule regime.
Mapp’s group is also simultaneously pursuing an al-
ernative method for the development of potent activa-
ors [16]. This approach involves screening of synthetic
eptide libraries to isolate short ADs that target spe-
ific components of the transcription machinery. In the
eported case, peptides that target Gal11 (Med15), a
omponent in yeast mediator complex, were isolated.
key finding in this paper was that the binding affinities
f the peptides for Gal11 may not be the sole determi-
ants of their activities, but that binding sites may also
lay significant roles. Schepartz and coworkers arrived
t a similar conclusion through their studies on the min-
protein activators [11]. Together these efforts pave the
ay to the development of potent activators by sys-
ematically analyzing and targeting protein surfaces
ound in the transcriptional complex.
In this issue of Chemistry & Biology, Mapp and co-
orkers show that the activity of the isolated peptide-
Ds is sensitive to the nature and location of the DBD
nd to the presentation of the ADs on the DBD. TheseA minimal artificial activator composed of two separate functional do-
mains: a DNA binding domain (DBD) and an activation domain (AD).
Previews
263garding the location of the DBD relative to the initiation
site and its effect on transcription activation. Signifi-
cantly, the authors show that the artificial activators are
only functional in the cells that contain the target pro-
tein. This level of specificity is uncommon in natural
activators and constitutes a promising advance in the
field [17].
The work summarized above describes continuing
fundamental advances at the interface of chemistry and
biology toward artificial control of gene expression. The
latest addition by Mapp and colleagues provides a con-
crete foundation for designing a new generation of cell-
type-specific and species-specific artificial activators.
Certainly, much remains to be elucidated, because the
ultimate goal is to generate cell-permeable transcrip-
tion factors that not only turn gene transcription on or
off but respond to extracellular signals as part of signal
transduction cascades [3]. However, we can anticipate
that chemists will continue to bring fresh perspectives
and a zest for understanding biology at the molecular
level to this highly fertile ground for exciting research.
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